Congress nudges FDA on issuing final NDI guidance

WASHINGTON — A total of 27 members of Congress on Monday issued a kind reminder to the Food and Drug Administration that many leaders across Capitol Hill are keeping tabs on New Dietary Ingredient guidance. 

The bipartisan correspondence, signed by key members on the Energy and Commerce Committee and the Dietary Supplement Caucus, praised the agency for its work with industry toward creating NDI notification processes. 

"We appreciate the agency's willingness to engage with industry on this important issue and work toward a revised guidance that reflects a fair and workable NDI notification system, based on the principles outlined in the Dietary Supplement Health and Education Act," the letter reads. "However, we remain concerned about the speed of progress on these discussions and when we can expect the agency to release a revised guidance. … We hope that you will work toward completion in a timely manner."

Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

Login or Register to post a comment.